Deutsche Bank Ag\ Dice Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$25.86 - $46.71 $148,488 - $268,208	-5,742 Reduced 24.24%	17,948 $833,000
Q1 2023 May 15, 2023	BUY	$26.05 - $32.31 $170,731 - $211,759	6,554 Added 38.25%	23,690 $678,000
Q4 2022 Feb 13, 2023	BUY	$19.77 - $42.23 $110,751 - $236,572	5,602 Added 48.57%	17,136 $534,000
Q3 2022 Nov 14, 2022	SELL	$14.97 - $22.65 $28,293 - $42,808	-1,890 Reduced 14.08%	11,534 $234,000
Q2 2022 Aug 11, 2022	BUY	$13.19 - $22.1 $70,803 - $118,632	5,368 Added 66.63%	13,424 $208,000
Q1 2022 May 13, 2022	SELL	$14.54 - $25.02 $5,917 - $10,183	-407 Reduced 4.81%	8,056 $154,000
Q4 2021 Feb 11, 2022	BUY	$22.41 - $37.54 $189,655 - $317,701	8,463 New	8,463 $214,000

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.